VEGFA and inflammatory breast carcinoma: The relationship between the concentration of the proangiogenic factor VEGF, pro-inflammatory cytokine IL-6, their correlation, and the objective response to treatment (by the degree of regression), which evaluated the direct effect of neoadjuvant therapy in patients with IBC, was determined.